BioCryst (BCRX) Soars 13% on Acquisition Buzz [Yahoo! Finance]
BioCryst Pharmaceuticals, Inc. (BCRX)
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
biocryst.gcs-web.com/investor-relations
Company Research
Source: Yahoo! Finance
BioCryst snapped a three-day losing streak on Monday, jumping 13.14 percent to finish at $9.30 apiece, as investors loaded portfolios amid rumors that it is set to be acquired by a large-cap biopharmaceutical company. Murmurs about the supposed acquisition broke out on a UK-based website about deals and dealmakers on Monday, saying that a US-based pharmaceutical giant is setting its sights on BioCryst Pharmaceuticals Inc (NASDAQ:BCRX). As of writing, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) has yet to confirm or deny the said report. BioCryst (BCRX) Soars 13% on Acquisition Buzz BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. Last month, it announced strong earnings performance in 2025, having swung to a net income of $263.86 million last year from an $88.88 million net loss in 2024. Total revenues soared by 94 percent to $874.8 million
Show less
Read more
Impact Snapshot
Event Time:
BCRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCRX alerts
High impacting BioCryst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
BCRX
News
- BioCryst: The Buyout Rumor Is Noise, The Franchise Is Real [Seeking Alpha]Seeking Alpha
- BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush [Yahoo! Finance]Yahoo! Finance
- BioCryst Pharmaceuticals (BCRX) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d-)" to "hold (c)".MarketBeat
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
BCRX
Earnings
- 2/26/26 - Beat
BCRX
Sec Filings
- 3/16/26 - Form 144
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- BCRX's page on the SEC website